You are here: Industry Insights > expansion

News List

Cambrex Completes Edinburgh Expansion contractpharma
October 14, 2020
Doubles the facility's footprint to 15,000 sq.-ft., existing lab space is refurbished, and an additional 3,500 sq.-ft. of lab space added.
Metrics Contracts Services Begins $10M Plant Expansion contractpharma
September 23, 2020
Adds 3,760 square feet of production space to the current facility, providing added flexibility and capacity to the CDMO.
Bushu Pharmaceuticals Unveils Major Expansion Program contractpharma
August 19, 2020
Japanese CDMO will invest $100 million to expand capacity and portfolio, Koichiro Matsumoto named president and CEO.
BioStem Life Sciences Announces Expansion contractpharma
March 19, 2020
New lab will support the research and development pipeline for the Company's growing Contract Development and Manufacturing (CDMO) business.
Sihuan Pharmaceutical Accelerates Product Expansion in Digestive System and Liver Related Diseases prnasia
February 14, 2020
Anaprazole sodium is the only self-developed proton pump inhibitor ("PPI") in the PRC, with Chinese and international patents.
MedPharm Triples Capacity at RTP Site ContractPharma
December 11, 2019
MedPharm, a provider in topical and transdermal drug delivery, has moved into its newly expanded facility in Durham, NC.
denovoMATRIX Introduces Ready-To-Use, Chemically Defined Coated Cell Cultureware for Serum-Free hMSC Expansion b3cnewswire
August 27, 2019
Due to their high accessibility and extensive beneficial properties, human Mesenchymal Stem Cells (hMSC) offer exciting promises in a plethora of applications in regenerative medicine...
Boston Analytical Continues Expansion contractpharma
August 16, 2019
Opens office in Cambridge spurred by double-digit growth.
Vetio Completes Plant Expansion in Montreal contractpharma
August 05, 2019
Facility produces liquids, semi-solids, tablets, intermediates and blends.
Lonza Expands Bioconjugation Facility and Third Commercial ADC Approved contractpharma
July 25, 2019
Expansion of bioconjugation in Visp to meet increasing clinical, launch and commercial market demand.

Previous page 1 2 3 4 5 Next page